[A25-73] Rimegepant (prophylaxis of migraine) – Benefit assessment according to §35a Social Code Book V
Last updated 26.08.2025
Project no.:
A25-73
Commission:
Commission awarded on 30.05.2025 by the Federal Joint Committee (G-BA).
Report type:
Dossier assessment
Status:
Commission work started
Department/Division:
Drug Assessment
Topic:
Head and nerves
| Project no. | Title | Status |
|---|---|---|
| A25-72 | Rimegepant (migraine, acute treatment) – Benefit assessment according to §35a Social Code Book V | Commission work started |